chrisvoncsefalvay/vaers-outcomes huggingface dataset:
About 36 hrs post flu vaccine, pt developed heart symptoms & went to local hospital.  Dx: atrial flutter/fibrillation & ventricular tachycardia & skipped or stopped ventricular function.  Pt had several IV drug txs that were unsuccessful.  While waiting for ambulance w/ IV capability, condition resolved on its own.  All cardiac tests returned normal.  A lesser episode occurred ~1 month later.  4/18/08 MR received from local hospital for DOS 2/22/08 with DX: Atrial Fibrillation with rapid ventricular response.  Pt presented with new onset palpitations.  PE (+) for irregular heartrate. Pt converted to Sinus rhythm with Cardizem drip. Pt transfered to ICU for higher level of care.  4/30/2008 MR received from transfer hospital for DOS 2/22-23/2008 with D/C DX: Acute onset of Atrial Fibrillation which cardioverted with inferior R waves to a normal sinus rhythm. (17 additional dx as per PMH and Labs). Pt had converted to sinus rhythm prior to admission
Unexpected early menstrual period (14 day cycle). Normal length and flow level and other associated symptoms like cramping, compared to typical. An additional unexpected early menstrual period started Nov. 16 (12 day cycle). My typical cycle length is 30-45 days, and previous shortest ever cycle was 25 days.
redness in the palm; Itching in the Palm; Rash on the palm of the hand; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness in the palm), PRURITUS (Itching in the Palm) and RASH (Rash on the palm of the hand) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 028L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] and VITAMINS NOS for an unknown indication.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Mar-2021, the patient experienced ERYTHEMA (redness in the palm), PRURITUS (Itching in the Palm) and RASH (Rash on the palm of the hand). At the time of the report, ERYTHEMA (redness in the palm), PRURITUS (Itching in the Palm) and RASH (Rash on the palm of the hand) had not resolved. Unknown          No treatment information was provided. The action taken for mRNA-1273 was not applicable.
Next day after the vaccination, the patient(staff member) came back to the vaccination clinic and stated that she felt numbness and tingling along the smile lines of her face and around her lips. She was monitored for about 40 minutes then she reported difficulty of swallowing. At first reported symptom of swallowing difficulty she as administered diphenhydramine 50 mg oral liquid by mouth. After about 30 minutes of continued monitoring, epinephrine 0.3 mg IM was administered. At the same time 911 emergency response was called and the patient was transferred to the acute care hospital.
cannot move my finger; Pain in Finger/ Pain in leg/ he started experiencing pain in his first finger or thumb/ thumb is in a lot of pain/ lot pain in his hands; unable to walk; He has not been able to go to work due to this problem; This spontaneous case was reported by a patient and describes the occurrence of HYPOKINESIA (cannot move my finger), PAIN IN EXTREMITY (Pain in Finger/ Pain in leg/ he started experiencing pain in his first finger or thumb/ thumb is in a lot of pain/ lot pain in his hands), GAIT INABILITY (unable to walk) and IMPAIRED WORK ABILITY (He has not been able to go to work due to this problem) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20-2A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 24-May-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-May-2022, the patient experienced HYPOKINESIA (cannot move my finger), PAIN IN EXTREMITY (Pain in Finger/ Pain in leg/ he started experiencing pain in his first finger or thumb/ thumb is in a lot of pain/ lot pain in his hands) and GAIT INABILITY (unable to walk). In 2022, the patient experienced IMPAIRED WORK ABILITY (He has not been able to go to work due to this problem). At the time of the report, HYPOKINESIA (cannot move my finger), PAIN IN EXTREMITY (Pain in Finger/ Pain in leg/ he started experiencing pain in his first finger or thumb/ thumb is in a lot of pain/ lot pain in his hands), GAIT INABILITY (unable to walk) and IMPAIRED WORK ABILITY (He has not been able to go to work due to this problem) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. It was unknown whether the patient had any allergies or COVID.  Patient did not receive any vaccine within 1 month prior to Moderna COVID-19 vaccine. The patient did not have similar events in the past. Events got worsened, patient visited his primary care physician.  No treatment medication was reported.
Patient called in to report symptoms after her first COVID-19 vaccine. She had received the Moderna vaccine on 3/3/2021 at the fairgrounds. She states she her appointment was for 9:55am on 3/3/21. Patient states symptoms started about four hours later and that she developed pain and redness at the vaccination site which made it painful to touch.  Patient then reported that the symptoms stopped by 3/5/21.  She states that symptoms had resolved until she developed itching at the vaccination site on 3/10/21.  Symptoms continued with itching and redness on 3/11/21. Patient referred to her primary care physician for follow up. Patient called on 3/18/21 and she stated that her symptoms had completely resolved.
This spontaneous report as received from a pharmacist refers to an unspecified number of patients of unknown age and gender. On an unknown date the patients were vaccinated with ZOSTAVAX (dose, route, lot numbers and expiration dates not reported. On an unknown dates the patients experienced redness and itching at the ZOSTAVAX injection sites. At the time of the report the outcome of the events was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
pt devel erythema, swelling, scaling & itching about the medial periorbital area bilaterally w/edema of the eyelids w/in 24 hrs of receiving Td vax;
2 days post injection onset of pain in rat shoulder join that has persistent up to this point and seemed to get progressively worse over time. Excruciating at times and only when performing certain movements. Worse at night time
she could have had a mild stroke; Headache; stroke type symptoms of confusion, difficulty talking and right side of face felt funny; stroke type symptoms of confusion, difficulty talking and right side of face felt funny; stroke type symptoms of confusion, difficulty talking and right side of face felt funny; This is a spontaneous report from a contactable consumer from a Pfizer-sponsored program. A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got a headache after covax last week Wednesday. On Thursday (unknown date), she had stroke type symptoms of confusion, difficulty talking and right side of face felt funny. The patient was taken to the emergency room on Friday and they said she could have had a mild stroke even though her tests were all negative. The outcome of the events was unknown.  Information on the lot/batch number has been requested.
This case was reported by a physician via call center representative and described the occurrence of fainting in a 11-year-old female patient who received BEXSERO. On an unknown date, the patient received BEXSERO at an unknown dose. On an unknown date, unknown after receiving BEXSERO, the patient experienced fainting and wrong drug administered. On an unknown date, the outcome of the fainting and wrong drug administered were unknown. It was unknown if the reporter considered the fainting to be related to BEXSERO. Additional details were reported as follows: It was reported that the health care professional should have given a MENVEO to the patient but gave a BEXSERO, which led to wrong drug administered. The reporter had limited information and had no product information.
This spontaneous report as received from a pharmacist refers to a patient (id# 746) of unknown age. The patient was vaccinated with improperly stored PNEUMOVAX23 on 18-AUG-2012. Lot# was reported as 0217AE, expiration date: 22-AUG-2013. Route was unspecified. No adverse events reported. The vaccine storage information was reported as "From 04-AUG-2012 to 09-AUG-2012, lowest temp excursion exposed to -1.7C for 65 minutes and exposed to 0C to 2C for total of 80 minutes. High temp excursion exposed to 11.1C for total of 322 minutes (5.4 hrs). From 12-AUG-2012 to 14-AUG-2012, lowest temp excursions at -1.9C for 153 minutes, -0.5C for 90 minutes, 30 minutes and 60 minutes and exposed to 0C to 2C for total time of 407 minutes. From 14-AUG-2012 to 28-AUG-2012, lowest temp excursions at -8.3C for total of 9 hours (2 excursions), -3.6C for total of 19 hours (2 excursions), -4.8C for total of 12 hours (4 excursions) and -5.7C for total of 9.5 hours (2 excursions). High temp excursion exposed to 18.4C for 1 hour and 10 minutes." This is one of several reported received from same source. 1209USA007525, 1209USA008597, 1209USA008599, 1209USA008600, 1209USA008601, 1209USA008602, 1209USA008603, 1209USA008604, 1209USA008605, 1209USA008606, 1209USA008607, 1209USA008608, 1209USA008609, 1209USA008610, 1209USA008611, 1209USA008612, 1209USA008613, 1209USA008614. Additional information has been requested.
p/vax pt exp diarrhea x5days;vomiting;lethargic episode & one bloody stool; sent to hosp for BE-was reduced
No adverse effects; one separate dose of an improperly stored vaccine, PEDVAXHIB was administered to one separate patient.; Information has been received from a medical assistant, referring to a patient of unknown age and gender. Information of concomitant therapy, pertinent medical history and drug reactions/allergies was not reported.    On 18-JUN-2019, the patient was vaccinated with improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate)(LIQUID PEDVAXHIB) 0.5 milliliter (one dose, lot# R021077, expiration date: 11-JUN-2021, frequency was unknown) intramuscularly for prophylaxis (incorrect product storage). No adverse effect was reported.  The vaccines were exposed to temperature of 34.2 Fahrenheit (F) for 4 hour 54 minutes. The temperature excursion was detected by a data logger. No previous excursions were reported.  This is one of several reports from the same reporter.; Sender's Comments:  US-009507513-1906USA011674:
moderate sized oval shaped red patch (2 inch diameter) with slight itchiness, inflammation and stiffness.
had fever 103, unconsolable, crying all noc, red sore swollen leg, p/the DTP
I'm having bad reactions after the 2nd shot like pain, feverish, aching, tired. Ugh :(. Ouch  Yesterday I had the shot. This morning was a bit of delirium in my thinking and cold. Drinking tons of apple juice is helping to recover but my skin is sensitive. ??  I?m not a physically strong person at all and this makes me feel half disabled :(. Miserable... took a multivitamin and endlessly drinking apple juice to flush out my system.
Achiness; Arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Achiness) and PAIN IN EXTREMITY (Arm soreness) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced MYALGIA (Achiness) and PAIN IN EXTREMITY (Arm soreness). At the time of the report, MYALGIA (Achiness) and PAIN IN EXTREMITY (Arm soreness) outcome was unknown.            Concomitant product use was not provided by the reporter.   ? Patient wanted to know if it was okay to take Aspirin ? The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the mRNA-1273 in response to the events was not applicable. ? Action taken with mRNA-1273 in response to the event was not applicable.
Was given 1st moderna injection 3 days later had Afib attack, chest pain. Had cardio ablation 6/2019 to stop Afib and had no problems until after vax
I had low grade fever, fatigue and minor joint pain after the second dose of the Moderna. On May 19th 2021 I saw my DR via atelemedicine appointment. On the 16th of May I had felt feverish and fatigued and all that, I explained to my DR that I did have these same symptoms as when I had Covid in December of 2020. I did a Covid test in May of 2021 and it was negative. The DR thought that the symptoms were just due to the vaccination or something viral.
9DEC98 pt recv vax & 16DEC98 T104.6 went to MD given ATB (broke out in hives MD d/c med;27DEC98 8 pox marks-groin, face, hands;
Standard work was not followed and patient was given 0.5mL instead of 0.25mL.
With the first 3 doses she usually gets a bump on the injection site; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58-year-old female patient received BNT162b2 (BNT162B2), on 29Sep2021 as dose 1, single (Lot number: FF8839) at the age of 56 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Autoimmune disease" (unspecified if ongoing); "hard to walk" (unspecified if ongoing); "hands go numb" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Prednisone, reaction(s): "inflammation disease". The following information was reported: VACCINATION SITE MASS (non-serious), outcome "not recovered", described as "With the first 3 doses she usually gets a bump on the injection site". Relevant laboratory tests and procedures are available in the appropriate section.  Additional Information: It was reported that, the patient had attacks where it was hard to walk and use her hands because they go numb. The patient Sed rate and C-reactive proteins were high. The patient was told it was inflammation disease. She was on prednisone for 2 years. Had test after test. Does not know the name of her disease. The patient was not on Prednisone anymore. Does not know if the prednisone helped whatever it was as she was able to walk and use her hands now. The patient did not receive other vaccines within four weeks prior to COVID vaccine.
08:13  received 2nd dose Moderna.  It wasn't until after, that the Doctor was notified   had a severe reaction from 1st dose on 3/3/2021. That episode required 2 doses of EPI and transport to ER.  stated she took a Zyrtec at 0700 prior to second dose of VACC.  08:20  felt warm, maybe chest heaviness, no difficulty breathing, swallowing. 08:25 Tired, lips felt swollen, maybe some lip tingling 08:34 Nausea 08:40 Benadryl 50 mg given 08:56 Dizzy, lightheaded, nauseated 09:00 Vomiting x 1 09:14 EPI 0.3 given by EMS 09:33  went to ER Via ambulance;  was conversing comfortably. A&O x 3.
I developed symptoms in the evening of January 30. My chest felt hot on the inside and I had a little bit of fever. I took a rapid at home test for COVID19 and was positive. The next day, Tuesday, I had a pretty good sized fever, and was really really snotty. A bit of a cough but not much, my chest was still a little tight. My fever only got to 102, and I slept a lot. On Wednesday I felt better, other than being tired and I developed diarrhea. It wasn't chronic as in several times a day, but any time I went it was loose and unformed stools. That lasted about 5 days or so. When I spoke with my PCP's office on Tuesday the recommended I not take the Paxlovid because of my AFIB medications, and if I got worse or had issues breathing to go to the ER, but I didn't need to.
Initial information received on 07-Sep-2018 regarding an unsolicited valid non-serious case received from a nurse. This case involves two months old female patient who was vaccinated with 0.25 ml dose of QUADRIVALENT INFLUENZA VACCINE (lot no UI983AA and Exp. Date 30-06-2019) via unknown route in the left thigh on 07-Sep-2018. The patients medical history not reported and No concomitants. No known reported symptoms. It was an actual medication error due to 0.25 ml of FLUZONE QUADRIVALENT was given to two months old female patient (drug administered to patient of inappropriate age). No any information about adverse event reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of documents held by sender: none.
Feet started itching; Feet swollen; Feet hurting; Can not move her toes; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (Feet started itching), PERIPHERAL SWELLING (Feet swollen), PAIN IN EXTREMITY (Feet hurting) and PERONEAL NERVE PALSY (Can not move her toes) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included UTI. Concomitant products included LISINOPRIL for an unknown indication.   On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced PRURITUS (Feet started itching), PERIPHERAL SWELLING (Feet swollen), PAIN IN EXTREMITY (Feet hurting) and PERONEAL NERVE PALSY (Can not move her toes). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PRURITUS (Feet started itching), PERIPHERAL SWELLING (Feet swollen), PAIN IN EXTREMITY (Feet hurting) and PERONEAL NERVE PALSY (Can not move her toes) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Shingles (right hip pain began on 5/14/21, 5/18/21  developed a rash along the nerve pathway with continued pain and puritis. ) Started on valACYclovir 1000 MG tablet TID. 5/18/21.  Treatment is ongoing.
chills and fever--worst day 1 but another bout on day 2; exhaustion; headache; hard lump under skin at vaccination site; significant site pain; significant heat emanating from site; red circle on skin around injection site; clear blister formed at injection site
Tested positive for COVID-19 on 12/4/2022 I had a high fever, body aches, high fever 103. headaches, brain fog, and a dry cough. I started feeling better by the 5th day of taking PAXLOVID. I still have a lingering dry cough that seems to be exacerbated by drinking cold drinks. I took OTC DELSYM and MUCINEX.
After getting flu shot she got fevers in 2 hours. Fever goes up and down for 7 days and also she got constipated for 5 days. So she took stool softener on 5th day to recover constipation. She took 3 TYLENOL total in week.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. In July 2013 the patient was vaccinated with the first dose of GARDASIL (dose, route, lot number and expiration date not reported). On an unspecified date in 2013, the patient was vaccinated with the second dose of GARDASIL (dose, route, lot number and expiration date not reported). On 26-SEP-2014, the patient was scheduled to be vaccinated with the third dose of GARDASIL (dose, route, lot number and expiration date not reported). No adverse effects reported. Additional information has been requested.
1hr p/vax pt became febrile & started vomiting;cont for 12hr;did not inform MD office until 4MAR98 @ 18mo;
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). A 15-year-old male patient received BNT162b2 (BNT162B2), on 11Jun2021 as dose 2, single (Lot number: EP7533) at the age of 14 years for Covid-19 immunisation. The patient's relevant medical history included: "allergic to milk" (unspecified if ongoing), notes: After vaccine, appears to be allergic to, milk. The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose Number: 1, Batch/Lot No: EW0173, brand: Pfizer), administration date: 21May2021, when the patient was 14-year-old, for COVID-19 Immunization. The following information was reported: EOSINOPHIL COUNT INCREASED (medically significant) with onset Oct2021, outcome "recovered with sequelae", described as "increased eosinophil counts in the esophagus"; MILK ALLERGY (medically significant) with onset Oct2021, outcome "recovered with sequelae", described as "severe allergy to milk". The events "severe allergy to milk" and "increased eosinophil counts in the esophagus" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: Eosinophil count: (Oct2021) increased, notes: in the esophagus. Therapeutic measures were taken as a result of milk allergy, eosinophil count increased. No follow-up attempts are possible. No further information is expected.
Severe syncope vertigo dizziness pressure headache in my head and in my neck .  I need to go to the hospital twice tremors  The symptoms have been debilitating I?m having tachycardia every time I stand up and I?m having to take Xanax because of my panic attacks.
blurred vision, chest tightness, and trouble breathing shortly after receiving first dose of Moderna. Patient experienced blurred vision, chest tightness, and trouble breathing shortly after receiving first dose of Moderna. She was given 1 dose from Epi Pen and was taken away by the paramedics.
Patient stated he had violent shaking (asked him to check blood sugars and stated he was at 119)- for 7 hours after vaccine, told him to go to urgent care to be check out